Hormone therapy for hot flashes in women living with HIV
Official title: Menopausal Hormone Therapy for Women Living With HIV (HoT)
Run by Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections · NCT06856174 · Data updated 2026-11-12
This study tests whether transdermal estradiol (with or without progesterone) can relieve hot flashes and improve quality of life for women living with HIV who are going through menopause.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 40 Years to 60 Years |
| Sex | Women only |
| Enrollment | 105 (estimated) |
| Sponsor | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections Research network |
| Locations | 23 sites (Birmingham, Alabama and 22 other locations) |
| Status | Recruiting |
| Started | April 9, 2026 |
| Main results expected | September 20, 2027 |
| Study ends | September 20, 2027 |
| Registry record updated | May 22, 2026 |
| Trial ID | NCT06856174 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 40–60 living with HIV, in late perimenopause or early postmenopause, who experience hot flashes or night sweats and meet safety criteria for hormone therapy.
✕Probably not a fit
Some participants may not experience symptom relief or may encounter side effects or contraindications that limit benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This Phase 4 trial will evaluate the safety and effectiveness of transdermal estradiol gel with or without micronized progesterone compared with placebos in women living with HIV who are late perimenopausal or early postmenopausal and experience hot flashes or night sweats. Participants will use daily diaries to track symptoms and daily functioning, sleep, mood, and bone health measures. The study aims to determine if hormone therapy offers benefits beyond symptom relief, including improvements in mood, sleep, mental function, and bone health, without unacceptable risks. The trial is conducted at multiple centers in the United States and is sponsored with collaborators from NIAID, NIA, and Exeltis.
Why it matters
Potential benefit: If successful, participants may experience relief from hot flashes and night sweats and potential improvements in sleep, mood, and bone health.
How similar studies have gone: Prior hormone therapy trials show symptom relief in the general population, but data in women living with HIV are limited and this study adds specific evidence for this group.
Who can join: the full rules
Show full inclusion / exclusion criteria
* Living with HIV * Assigned female sex at birth * Between the ages of 40 and 60 years * In the late menopausal transition (perimenopause) or early postmenopause * Experiencing hot flashes and/or night sweats * Willing and able to complete a daily diary * Does not have medical condition that would contraindicate hormone therapy * Not taking medications to treat hot flashes * Not taking medications that cannot be combined with hormone therapy * Receiving antiretrovirals (HIV medication) for more than 1 year * Not pregnant and willing and able to use at least non-hormonal birth control to prevent pregnancy * Willing and able to provide informed consent after discussion with the research staff
Where it's running
-
31788 Alabama CRS
Birmingham, Alabama, United States Recruiting -
University of California, Los Angeles CARE Center CRS (601)
Los Angeles, California, United States Recruiting -
UCSD Antiviral Research Center CRS (701)
San Diego, California, United States Recruiting -
801 University of California, San Francisco HIV/AIDS CRS
San Francisco, California, United States Recruiting -
Harbor - UCLA Med. Ctr. CRS
Torrance, California, United States Recruiting -
University of Colorado Hospital CRS (6101)
Aurora, Colorado, United States Recruiting
Show 17 more locations
-
The Ponce de Leon Center CRS (5802)
Atlanta, Georgia, United States Recruiting -
Northwestern University CRS (2701)
Chicago, Illinois, United States Recruiting -
201 Johns Hopkins University CRS
Baltimore, Maryland, United States Recruiting -
101 Massachusetts General Hospital (MGH) CRS
Boston, Massachusetts, United States Recruiting -
Brigham and Women's Hosp. ACTG CRS (107)
Boston, Massachusetts, United States Recruiting -
2101 Washington University Therapeutics (WT) CRS
St Louis, Missouri, United States Recruiting -
New Jersey Medical School Clinical Research Center CRS (31786)
Newark, New Jersey, United States Recruiting -
Weill Cornell Chelsea CRS (7804)
New York, New York, United States Recruiting -
Columbia Physicians and Surgeons (P&S) CRS (30329)
New York, New York, United States Recruiting -
3201 Chapel Hill CRS
Chapel Hill, North Carolina, United States Recruiting -
3203 Greensboro CRS
Greensboro, North Carolina, United States Recruiting -
2401 Cincinnati CRS
Cincinnati, Ohio, United States Recruiting -
Case CRS (2501)
Cleveland, Ohio, United States Recruiting -
Ohio State University CRS (2301)
Columbus, Ohio, United States Recruiting -
6201 Penn Therapeutics CRS
Philadelphia, Pennsylvania, United States Recruiting -
Univ of Pittsburgh
Pittsburgh, Pennsylvania, United States Recruiting -
Houston AIDS Research Team CRS (31473)
Houston, Texas, United States Recruiting
Study contacts
- Study coordinator: ACTG ClinicalTrials.gov Coordinator
- Email: ACTGCT.gov@dlhcorp.com
- Phone: 301-628-3348
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Hop extract vs soy isoflavone for menopausal symptoms
This study tests whether a full-spectrum hop extract helps reduce menopausal mood symptoms better than soy isoflavones in peri- and postmenopausal women.
-
Resveratrol and Estrogen Receptors in Postmenopausal Women with CAD
This study tests whether taking resveratrol is safe and can change estrogen-related markers in postmenopausal women with coronary artery disease.
-
Ashoka Bark and Shatavari for Menopause
This 12-week study tests whether a daily Ashoka Bark and Shatavari supplement helps reduce menopausal symptoms in postmenopausal women compared with a placebo.
-
Lifestyle changes to ease menopausal symptoms, sleep problems, and anxiety
Researchers are testing whether a structured lifestyle education program helps perimenopausal and postmenopausal women see fewer menopausal symptoms, better sleep, and less anxiety compared to usual care.
-
Pain and period life: does menstrual cycle or menopause change pain during root canals?
This study will see if pain during a root canal varies with menstrual cycle phase or menopausal status in adult patients.
-
Sex hormones, menopause, and exercise in aging women
This study tests how hormonal status and resistance training affect age-related muscle and nerve function in postmenopausal women.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.